Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.

Biotechnologijos

Ms. Angelika  Florvaag

Chief Quality Officer

Mr. James  Berger

Chief Commercial Officer

Ms. Christel Elise Kanli

Chief Financial Officer & Chief Operating Officer

Dr. Bomi  Framroze

Chief Scientific Officer

Mr. Jon Olav Odegard

Chief Executive Officer

Pavadinimas	Rinkos kapitalizacija
Maravai LifeSciences Holdings, Inc.	0M
Gubra A/S	0M
CytoTools AG	0M
Shanghai Haohai Biological Technology Co., Ltd.	0M
Purple Biotech Ltd.	0M
Artelo Biosciences, Inc.	0M
Starpharma Holdings Limited	0M

Hofseth BioCare ASA

Hofseth BioCare ASA Konkurentų sąrašas

Pagrindiniai konkurentai